Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 15;10(10):1722.
doi: 10.3390/vaccines10101722.

Barriers and Facilitators of Romanian HPV (Human Papillomavirus) Vaccination

Affiliations

Barriers and Facilitators of Romanian HPV (Human Papillomavirus) Vaccination

Loredana Sabina Cornelia Manolescu et al. Vaccines (Basel). .

Abstract

Background: Many countries had initial success with HPV vaccination campaigns worldwide. The HPV vaccine coverage during the COVID-19 pandemic dropped consistently. The aim of our research is to assess the barriers and facilitators of the current Romanian HPV vaccination campaign.

Methods: An analytical cross-sectional observational survey was conducted in the Romanian general population; a self-administered questionnaire was used.

Results: 1122 responders were interviewed; 666 (59.36%) were parents, and 67 (5.97%) HPV vaccinated themselves. A multinominal logistic regression carried out in the parents' category showed that women with university studies and informed from medical sources have greater chances to HPV vaccinate. Reticence regarding vaccination comes from the high cost of the vaccine and a lack of information. Only 118 (10.51%) vaccinated against HPV. From the logistic regression analysis, gender (ORa 0.461 = 95% CI: (0.196; 1.083)), geographic area of residence (ORa = 0.517; 95% CI: (0.331; 0.807)), and the inclusion of the HPV vaccine in the National Vaccination Program (ORa = 2.4; 95% CI: (1.361; 4.235)) were the factors found most associated with HPV vaccination.

Conclusions: In the general population, the inclusion of HPV vaccination in the National Vaccination Program would be the most important facilitator of HPV vaccination in Romania. In parents that did not vaccinate their children, one important barrier to HPV vaccination was the high cost of the HPV vaccine and the lack of proper information. The acceptability of HPV vaccination in Romania is low; therefore, public health educational programs are needed.

Keywords: HPV vaccination; children vaccination; human papillomavirus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Manolescu L.S.C., Mitran C.I., Mitran M.I., Georgescu S.R., Tampa M., Suciu I., Suciu G., Popa G.L., Popa M.I. Knowledge, attitudes and beliefs about HPV infection and HPV vaccines in Romanian medical students. Arch. Microbiol. Immunol. 2021;80:22–35. doi: 10.54044/RAMI.2021.01.04. - DOI
    1. Tampa M., Mitran C.I., Mitran M.I., Nicolae I., Dumitru A., Matei C., Manolescu L., Popa G.L., Caruntu C., Georgescu S.R. The Role of Beta HPV Types and HPV-Associated Inflammatory Processes in Cutaneous Squamous Cell Carcinoma. J. Immunol. Res. 2020;2020:5701639. doi: 10.1155/2020/5701639. - DOI - PMC - PubMed
    1. Shapiro G.K. HPV Vaccination: An Underused Strategy for the Prevention of Cancer. Curr. Oncol. 2022;29:3780–3792. doi: 10.3390/curroncol29050303. - DOI - PMC - PubMed
    1. Vänskä S., Luostarinen T., Baussano I., Apter D., Eriksson T., Natunen K., Nieminen P., Paavonen J., Pimenoff V.N., Pukkala E., et al. Vaccination with Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied. J. Infect. Dis. 2020;222:948–956. doi: 10.1093/infdis/jiaa099. - DOI - PMC - PubMed
    1. Lehtinen M., Luostarinen T., Vänskä S., Söderlund-Strand A., Eriksson T., Natunen K., Apter D., Baussano I., Harjula K., Hokkanen M., et al. Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III) Int. J. Cancer. 2018;143:2299–2310. doi: 10.1002/ijc.31618. - DOI - PubMed

LinkOut - more resources